-The Hindu They seek waiver on some provisions of world agreements that regulate intellectual property rights to expedite steps to contain pandemic India and South Africa, in a formal submission to the World Trade Organization (WTO) on October 2, sought a waiver on certain provisions of the international agreements that regulate intellectual property rights to speed up efforts to prevent, treat and contain the COVID-19 pandemic. In the communication, the countries said there...
More »SEARCH RESULT
Total Matching Records found : 41
Bitter home truths for migrant workers -Sayantan Bera
-Livemint.com * Trying to start a new life is turning out to be difficult due to a collapse in demand. A ground report from Bihar. * Consumption of drugs has spiked to dangerous levels. So much so that cough syrup brands, sedative drugs like Netravet and an adhesive named Sunfix are household names ARARIA/ NEW DELHI: Bergachi Chowk is a busy intersection, a short ride away from Araria town in northern Bihar, an...
More »IMA 'shocked' over Patanjali’s Coronil claim, asks health minister to clarify
-PTI/ Livemint.com * Being Health Minister of the country, how justified is it to release such falsely fabricated unscientific product, the IMA statement said * The IMA statement further said: Can you clarify the time frame, time line for the so-called clinical trial of this said anti-corona product The Indian Medical Association (IMA) on Monday said that it shocked over Patanjali Ayurveda's "blatant lie of WHO certification" for Coronil tablet, which the company...
More »Experts raise questions over ‘hasty’ approval for COVID-19 vaccines -Jacob Koshy
-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...
More »How India plans to ensure safety and efficacy of covid-19 vaccines -Neetu Chandra Sharma
-Livemint.com India has adopted a cautious approach in granting approval to covid-19 vaccines as fast tracking, safety and efficacy remain primary concern NEW DELHI: Safety and efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country. The government's cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked...
More »
